Leuprolide acetate

Questions | Reviews

que pasa si se utiliza 2 ml. de diluyente en una inyección

que sucede cuando se le inyecta al paciente la solución del medicamento con 2 ml. del diluyente el medicamento es LUPRIDE DEPOT 3.75, EL PACIENTE ES TRATADO DE CANCER  A LA PRÓSTATA. Gracias de antemano por la respuesta.
by Ariel Eduardo García Pérez in Huánuco, Perú, 03/16/2008

Use of Leuprolide acetate (lupride depot) in treatment of fibroids

I am 31 years of age and wish to retain fertility. I had a miscarriage at 19 weeks most probably because of fibroids and underwent a laparatomy myomectomy for multiple fibroids. The fibroids have distorted my uterus and post surgery, I have now been a...
by Mariesa N in Mumbai, India, 12/28/2005

lupride depot

I have taken a lupride injection in india on the 6 may 2006 due to fibroid. I have seen my period for the month of may but have not had my period for june todate. I have put on weight by 3 kg and I feel sort of dizziness and nausea. I would like to kn...
by lisa in indian ocean, 08/24/2006


    Hi , my 7year old has been taking Lupride depot 3.75mg monthly for the past 8 months.      Since her last injection on the 23rd April 2009, she has been complaining of headaches quite often.     At least 3 o...
by Nayahmka De Freitas in Trinidad and Tobago, West Indies., 05/01/2009

Lupride depot

Hi, I had undergone laproscopic surgery 6 months back fro correct endometriosis (chocolate cysts). Immediately after that, i was given Lupride depot injection (11.25 mg). I was told that my menses would  be stopped for 3 months. But its almo...
by Meenu in India, 04/20/2008

View All 16 Questions

Leuprolide acetate
Leuprolide acetate (Lupron)
Leuprolide acetate
(loo- PROH-lyd)
Pregnancy Category: X Lupron Lupron/Lupron Depot Lupron/Lupron Depot 7.5 mg/22.5 mg Lupron Depot 3.75 mg Lupron Depot Lupron Depot--3 Month Lupron Depot--4 Month Lupron Depot-Ped Lupron for Pediatric Use (Rx)

Classification: Antineoplastic agent, hormonal

See Also: See also Antineoplastic Agents .

Action/Kinetics: Related to the naturally occurring GnRH. By desensitizing GnRH receptors, gonadotropin secretion is inhibited. Initially, however, LH and FSH levels increase, leading to increases of sex hormones. However, decreases in these hormones will be observed within 2-4 weeks. Peak plasma levels: 4 hr for various doses. t 1/2: 3 hr. Chronic use results in a measureable increase in body length, return to prepubertal state of reproductive organs, and cessation of menses (if present).

Uses: Palliative treatment in advanced prostatic cancer when orchiectomy or estrogen treatment are not appropriate. Endometriosis (use depot form). Central precocious puberty (use depot-PED form). In combination with iron supplements for the presurgical treatment of anemia caused by uterine fibroid tumors (use depot form). Investigational: With flutamide for metastatic prostatic cancer.

Contraindications: Pregnancy, in women who may become pregnant while receiving the drug, and during lactation. Sensitivity to benzyl alcohol (found in leuprolide injection). Undiagnosed abnormal vaginal bleeding. Hypersensitivity to GnRH or GnRH agonist analogs. The 30-mg depot in women.

Special Concerns: Safety and efficacy have not been determined in children (except depot-PED). May cause increased bone pain and difficulty in urination during the first few weeks of therapy for prostatic cancer.

Side Effects: Injection and Depot. G I: N&V, anorexia, diarrhea, constipation, taste disorders/perversion, gingivitis, dysphagia, hepatic dysfunction. CNS: Pain, depression, emotional lability, insomnia, headache, dizziness, nervousness, paresthesias, anxiety, memory disorder, syncope, personality disorder, somnolence, spinal fracture/paralysis. CV: Peripheral edema, angina, cardiac arrhythmias, TIA/stroke hypotension, vasodilation. GU: Hematuria, urinary frequency or urgency, dysuria, testicular pain, incontinence, cervix disorder, penile swelling, prostate pain. Respiratory: Dyspnea, hemoptysis, pneumonia, epistaxis, pulmonary infiltrates. Endocrine: Gynecomastia, breast tenderness, impotency, hot flashes, sweating, decreased testicular size, increased or decreased libido. Musculoskeletal: Myalgia, bone pain, pelvic fibrosis, ankylosing spondylosis. Dermatologic: Dermatitis, skin reactions, acne, seborrhea, hair growth, ecchymosis, hair loss, skin striae, erythema multiforme and other rashes, androgen-like effects. Ophthalmic: Ophthalmic disorder, abnormal vision. Other: Asthenia, diabetes, fever, chills, tinnitus, infection, body odor, hard nodule in throat, accelerated sexual maturation, hearing disorder, peripheral neuropathy.
Injection. C V: MI, pulmonary emboli. GI: GI bleeding rectal polyps, peptic ulcer. CNS: Lethargy, mood swings, numbness, blackouts, fatigue. Respiratory: Cough, pulmonary fibrosis pleural rub. Dermatologic: Carcinoma of the skin/ear, itching, dry skin, pigmentation, skin lesions. GU: Bladder spasms, urinary obstruction. Miscellaneous: Enlarged thyroid, inflammation, temporal bone swelling, blurred vision.

Depot. C V: Tachycardia, bradycardia, heart failure varicose vein, palpitations. GI: Dysphagia, gingivitis. CNS: Delusions, confusion, hypesthesia. GI: Duodenal ulcer, dry mouth, thirst, appetite changes. Respiratory: Rhinitis, pharyngitis, pleural effusion. Endocrine: Lactation, menstrual disorder. GU: Penis disorder, testis disorder. Ophthalmic: Conjunctivitis, amblyopia, dry eyes. Miscellaneous: Nail disorder, flu syndrome, enlarged abdomen, lymphedema, dehydration, lymphadenopathy.

Laboratory Test Alterations: Injection and Depot. Calcium. WBC. Hypoproteinemia. Injection: BUN, creatinine. Depot: LDH, alkaline phosphatase, AST, uric acid, cholesterol, LDL, triglycerides, PT, PTT, glucose, WBC. Platelets, potassium. Hyperphosphatemia, abnormal LFTs. Misleading results from tests of pituitary gonadotropic and gonadal function up to 4-8 weeks after discontinuing depot therapy.

How Supplied: Injection: 5 mg/mL; Kit: 5 mg/mL, 7.5 mg, 11.25 mg, 15 mg, 22.5 mg; Powder for injection: 3.75 mg, 7.5 mg. 11.5 mg, 15 mg, 30 mg

?Depot, Injection Advanced prostatic cancer.
Injection: 1 mg/day SC using the syringes provided. Depot (IM): 7.5 mg monthly, 22.5 mg q 3 months, or 30 mg q 4 months.
Central precocious puberty.
Injection: Initial: 50 mcg/kg/day SC as a single dose. Dose may increased by 10 mcg/kg/day, which is the maintenance dose. Depot-Ped: Initial: 0.3 mg/kg/4 weeks (minimum 7.5 mg) as a single IM dose.
Endometriosis, uterine fibroids.
3.75 mg IM once a month for at least 6 months for endometriosis and 3 months or less for uterine fibroids. If further treatment is contemplated, assess bone density prior to beginning therapy.

Leuprolide acetate Ratings

Overall Rating:



(based on 0 reviews)


Ease of Use:

Overall Satisfaction:



Sure is quiet in here. You can write the first review of Leuprolide acetate.